Home › Funds › Opaleye Management Inc. › COAG
Opaleye Management Inc. position in COAG
HEMAB THERAPEUTICS HOLDINGS · Health Care
Opaleye Management Inc. reported holding 47,652 shares of COAG (HEMAB THERAPEUTICS HOLDINGS) in its Q2 2026 13F filing — a position valued at US$1.8M, representing 0.16% of its reported portfolio and ranking #49 among its reported holdings. Opaleye Management Inc. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Opaleye Management Inc.'s COAG position evolved
Opaleye Management Inc. first disclosed a stake in COAG in Q2 2026 at 47,652 shares (US$1.8M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 47.65K | $1.75M | New |
About COAG and 13F data
COAG (HEMAB THERAPEUTICS HOLDINGS) is a Health Care company. 60 other funds we track also report a position in COAG — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$286.8M), Novo Holdings A/S (US$153.6M), Deep Track Capital, LP (US$132.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COAG
- RA CAPITAL MANAGEMENT, L.P. 7.81M sh · $286.81M · Q2 2026
- Novo Holdings A/S 4.18M sh · $153.55M · Q2 2026
- Deep Track Capital, LP 3.60M sh · $132.30M · Q2 2026
- Siren, L.L.C. 2.09M sh · $76.65M · Q2 2026
- Avoro Capital Advisors LLC 1.93M sh · $70.71M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.65M sh · $60.60M · Q2 2026
- Rock Springs Capital Management LP 575.43K sh · $21.14M · Q2 2026
More on Opaleye Management Inc.
FAQ
How long has Opaleye Management Inc. held COAG?
Opaleye Management Inc. has disclosed COAG holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Opaleye Management Inc.'s current position in COAG?
As of Q2 2026, Opaleye Management Inc. holds 47.65K shares of COAG (HEMAB THERAPEUTICS HOLDINGS), valued at $1.75M, representing 0.16% of its reported portfolio and ranking #49.
Has Opaleye Management Inc. been buying or selling COAG?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. newly opened its position in COAG.
Which other funds hold COAG?
Other major institutional holders of COAG include RA CAPITAL MANAGEMENT, L.P., Novo Holdings A/S, Deep Track Capital, LP, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.